Lisata Therapeutics, Inc. (LSTA)
USD 2.41
(1.69%)
USD 2.41
(1.69%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -20.03 Million | -21.17 Million | -22.24 Million | -8.82 Million | -18.88 Million | -19.98 Million |
| Net Income | -20.84 Million | -54.22 Million | -27.46 Million | -8.14 Million | -19.35 Million | -16.16 Million |
| Depreciation & Amortization | 189 Thousand | 69 Thousand | 55 Thousand | 63 Thousand | 65 Thousand | 225 Thousand |
| Deferred income taxes | -2.32 Million | - | - | - | - | - |
| Stock-based compensation | 2038.00 | 2.63 Million | 2 Million | 1.26 Million | 1.29 Million | 2.45 Million |
| Change in working capital | -462 Thousand | -831 Thousand | 647 Thousand | -2.31 Million | -1.12 Million | -5.34 Million |
| Other non-cash items | 1.37 Million | 31.18 Million | 2.51 Million | 307 Thousand | 232 Thousand | -1.14 Million |
| Investing Cash Flow | 10.1 Million | 28.91 Million | -54.89 Million | -7.27 Million | 21.43 Million | -4.7 Million |
| Investments in PPE | - | -285 Thousand | -60 Thousand | -20 Thousand | - | -134 Thousand |
| Acquisitions | - | -3.32 Million | 54.83 Thousand | 7257.00 | - | 2.55 Million |
| Investment purchases | -98.47 Million | -89.68 Million | -179.77 Million | -34.79 Million | -32.93 Million | -69.69 Million |
| Sales/Maturities of investments | 108.58 Million | 122.2 Million | 124.93 Million | 27.54 Million | 54.37 Million | 62.56 Million |
| Other Investing Activities | 10.1 Thousand | -3.32 Million | -54.83 Thousand | -7257.00 | 21.43 Thousand | 2.55 Million |
| Financing Cash Flow | 385 Thousand | -224 Thousand | 85.27 Million | 18.58 Million | 1.18 Million | 824 Thousand |
| Debt repayment | - | - | - | - | - | -159 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -91.00 | -267.00 | -248.00 | -148.00 | -130.00 | -403.00 |
| Common Stock Issuance | 476 Thousand | 43 Thousand | 85.5 Million | 18.72 Million | 1.31 Million | 1.03 Million |
| Other Financing Activities | -91 Thousand | -266.73 Thousand | -223.75 Thousand | -147.85 Thousand | -129.87 Thousand | -48 Thousand |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | 88 Thousand | -223 Thousand | 1.25 Million | -2.83 Million | -1.86 Million | -5.9 Million |
| Inventory | - | - | - | - | - | - |
| Other working capital | -550 Thousand | -608 Thousand | -603 Thousand | 522 Thousand | 742 Thousand | 552 Thousand |
| Cash at beginning of period | 32.15 Million | 24.64 Million | 16.51 Million | 14.03 Million | 10.29 Million | 34.16 Million |
| Cash at end of period | 22.59 Million | 32.15 Million | 24.64 Million | 16.51 Million | 14.03 Million | 10.29 Million |
| Capital Expenditure | - | -285 Thousand | -60 Thousand | -20 Thousand | - | -134 Thousand |
| Effect of forex changes on cash | -16 Thousand | -10 Thousand | - | - | - | - |
| Net cash flow / Change in cash | -9.56 Million | 7.5 Million | 8.13 Million | 2.48 Million | 3.73 Million | -23.86 Million |
| Free Cash Flow | -20.03 Million | -21.45 Million | -22.3 Million | -8.84 Million | -18.88 Million | -20.12 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -5.04 Million | -5.4 Million | -5.36 Million | -20.84 Million | -5.26 Million | -4.02 Million |
| Depreciation & Amortization | 45 Thousand | 46 Thousand | 47 Thousand | 189 Thousand | 47 Thousand | 47 Thousand |
| Deferred income taxes | - | - | 826 Thousand | -2.32 Million | - | 325 Thousand |
| Stock-based compensation | 237.00 | 454 Thousand | 473 Thousand | 2.03 Million | 307 Thousand | 583 Thousand |
| Change in working capital | -388 Thousand | -2.07 Million | 1.02 Million | -462 Thousand | 1.6 Million | -528 Thousand |
| Other non-cash items | 194 Thousand | 1.73 Million | -1.07 Million | 1.37 Million | -283 Thousand | -584 Thousand |
| Investing Cash Flow | 11.71 Million | 6.43 Million | -5.71 Million | 10.1 Million | 12.25 Million | -725 Thousand |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | -100 Thousand | - | - | - | - |
| Investment purchases | -9.79 Million | -18.82 Million | -21.12 Million | -98.47 Million | -16.51 Million | -30.71 Million |
| Sales/Maturities of investments | 21.4 Million | 25.36 Million | 15.41 Million | 108.58 Million | 28.77 Million | 29.99 Million |
| Other Investing Activities | 100 Thousand | -100 Thousand | -5714.00 | 10.1 Thousand | 12.25 Thousand | -725.00 |
| Financing Cash Flow | 32 Thousand | -142 Thousand | 24 Thousand | 385 Thousand | -6000.00 | 452 Thousand |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | -142.00 | - | -91.00 | -6.00 | - |
| Common Stock Issuance | 32 Thousand | - | 24 Thousand | 476 Thousand | - | 452 Thousand |
| Other Financing Activities | 32.00 | -142 Thousand | 24.00 | -91 Thousand | -5994.00 | 452.00 |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | -950 Thousand | -1.24 Million | 1.39 Million | 88 Thousand | 747 Thousand | -969 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | 562 Thousand | -831 Thousand | -366 Thousand | -550 Thousand | 860 Thousand | 441 Thousand |
| Cash at beginning of period | 21.8 Million | 22.59 Million | 32.42 Million | 32.15 Million | 23.69 Million | 28.15 Million |
| Cash at end of period | 28.29 Million | 21.8 Million | 22.59 Million | 22.59 Million | 32.42 Million | 23.69 Million |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | 26 Thousand | -55 Thousand | -76 Thousand | -16 Thousand | 75 Thousand | -8000.00 |
| Net cash flow / Change in cash | 6.48 Million | -788 Thousand | -9.83 Million | -9.56 Million | 8.73 Million | -4.46 Million |
| Free Cash Flow | -5.28 Million | -7.02 Million | -4.06 Million | -20.03 Million | -3.58 Million | -4.18 Million |
RALLIS
PL8
AZY
5695
BAJAJELEC
6565